The aim of this prospective cohort study is to explore the clinical significance of sentinel lymph node imaging combined imaging examination evaluation in pelvic and peritoneal lymphadenectomy for endometrial carcinoma management.
The clinical data including surgical procedure, the situation of sentinel lymph node imaging and pathological results of patients with endometrial carcinoma treated in our hospitals between April 2019 and April 2021 will be analyzed in this study to clarify the homogeneity of imaging evaluation, sentinel lymph node development evaluation and pathological results.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
60
Patients in arm 2 will be randomized to undergo pelvic and peritoneal lymphadenectomy to treat their endometrial carcinoma.
the number (s) of pelvic and abdominal lymph node metastasis
the specific number of pelvic and abdominal lymph nodes that are invaded by metastatic endometrial carcinoma
Time frame: 1 year during the perioperative period
the percentage (%) of pelvic and abdominal lymph node metastasis
the specific percentage of pelvic and abdominal lymph nodes that are invaded by metastatic endometrial carcinoma
Time frame: 1 year during the perioperative period
the coincidence rate (%) of pelvic and abdominal lymph node imaging, sentinel lymph node imaging and pathological diagnosis
by performing chi-square test by SPSS 17.0，we plan to calculate the coincidence rate of three clinical examination
Time frame: 1 year during the perioperative period
the effect of pelvic lymphadenectomy on the prognosis of endometrial carcinoma patients
by setting up the control group and experimental group and conducting follow-up，we are determined to know whether pelvic lymphadenectomy would influence the prognosis of endometrial carcinoma
Time frame: 1 year during the perioperative period
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.